669. The clinical effectiveness of Fidaxomicin compared to Vancomycin in the treatment of Clostridioides difficile infection, a single center real-world experience

BACKGROUND: Clostridioides difficile infection (CDI) recurs in up to 25% of patients who achieve initial response to treatment. Therefore, the goal of treatment is to establish initial cure and prevent relapses. In this study, we examine the clinical effectiveness of fidaxomicin compared to vancomyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsoubani, Majd, Chow, Jennifer K, Rodday, Angie Mae, Kent, David, Snydman, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678595/
http://dx.doi.org/10.1093/ofid/ofad500.731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678595/
http://dx.doi.org/10.1093/ofid/ofad500.731

Ejemplares similares